We collaborated with BenchSci to better understand how Artificial Intelligence will shape the future of drug discovery, and what the barriers to entry are. We surveyed 330 members of the science advisory board to get their opinions on the subject, and hear about their experiences with Artificial Intelligence in drug discovery thus far. Click here to find out what we discovered.
The Science Advisory Board collaborated with Microbial Insights to bring us a look at some new technological advancements that will be shaping the future of laboratory equipment and workflow in 2018, as well an idea for how to turn your old laboratory equipment into a vital gift to those who need it most during the season of giving.
After a brief hiatus, we are relaunching our charity donation program, with donations to Direct Relief and the Tri-Beta Society. They are both doing excellent work in their fields and we are proud to be able to facilitate such generous giving from you, our members. Click here to learn more about what's changed, and how your donated points are being put to good use.
As we come to the end of our anniversary month, we felt that it would be exciting to hear from you, our members, about your experiences and memories as scientists from the past two decades. To that end, we sent some of you a survey and asked you to share some highlights, memories, and thoughts on the Science Advisory Board. Naturally, there were nearly as many unique responses to these questions as there were respondents, but within that there were some clear trends which stood out. Check out the responses below.
Our founder, Bill Kelly, looks back over twenty years of growth for The Science Advisory Board, and remembers the very first communication that went out to our members. Join us in looking back at our humble beginnings, and forward towards our future.
The emergence of CRISPR-Cas9 research is one of those rare developments in scientific history where a very complicated, difficult to understand issue has captured the imaginations of the media, and subsequently the public. Find out what our members have to say about the controversial topic of CRISPR-Cas9 engineered gene drives.
The Science Advisory Board has conducted global opinion research regarding the March for Science . This opinion research project is part of an internship program in partnership with the Biotechnology Graduate Program of Georgetown University. Reecha Badave, graduate student at Georgetown University, conducted this opinion research with Quentin Kreilmann, Manager of The Scientific Advisory Board.
The Science Advisory Board has conducted opinion research regarding The Food & Drug Administration (FDA), and federal regulations' effect on drug prices. This survey talks about the Trump Administration's proposed budget cuts and policy changes that would affect the FDA. It also enquires about Scott Gottlieb's nomination to lead the agency, the FDA's approval process and probe at the causes of increasing drug prices.
The Science Advisory Board has conducted a research study on the recent changes in the Environmental Protection Agency (EPA) under the Trump Administration and casted it amongst a wide range of EPA employees, environmental scientists, and scientists working for the … Read more
Shortly after the inauguration of 45th President, the United States Department of Agriculture (USDA) received an internal communication calling for a suspension of “public-facing documents”. Although not unprecedented, it marked the beginning of what looks to be a long term … Read more